Improving Change Impact Analysis with a Tight Integrated Process and Tool von Pirklbauer, Guenter, Fasching, Christian, Kurschl, Werner

Volltext bestellen

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment von Fasching, Peter A, Heusinger, Katharina, Haeberle, Lothar, Niklos, Melitta, Hein, Alexander, Bayer, Christian M, Rauh, Claudia, Schulz-Wendtland, Ruediger, Bani, Mayada R, Schrauder, Michael, Kahmann, Laura, Lux, Michael P, Strehl, Johanna D, Hartmann, Arndt, Dimmler, Arno, Beckmann, Matthias W, Wachter, David L

Volltext

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection von Schrauder, Michael G, Strick, Reiner, Schulz-Wendtland, Rüdiger, Strissel, Pamela L, Kahmann, Laura, Loehberg, Christian R, Lux, Michael P, Jud, Sebastian M, Hartmann, Arndt, Hein, Alexander, Bayer, Christian M, Bani, Mayada R, Richter, Swetlana, Adamietz, Boris R, Wenkel, Evelyn, Rauh, Claudia, Beckmann, Matthias W, Fasching, Peter A

Volltext

Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders von Fasching, Patrizia, Stradner, Martin, Graninger, Winfried, Dejaco, Christian, Fessler, Johannes

Volltext

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes von VON MINCKWITZ, Gunter, UNTCH, Michael, JACKISCH, Christian, KAUFMANN, Manfred, KONECNY, Gottfried E, DENKERT, Carsten, NEKLJUDOVA, Valentina, MEHTA, Keyur, LOIBL, Sibylle, BLOHMER, Jens- Uwe, COSTA, Serban D, EIDTMANN, Holger, FASCHING, Peter A, GERBER, Bernd, EIERMANN, Wolfgang, HILFRICH, Jörn, HUOBER, Jens

Volltext

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients von RACK, Brigitte, SCHINDLBECK, Christian, FEHM, Tanja, SCHNEEWEISS, Andreas, LICHTENEGGER, Werner, BECKMANN, Matthias W, FRIESE, Klaus, PANTEL, Klaus, JANNI, Wolfgang, JÜCKSTOCK, Julia, ANDERGASSEN, Ulrich, HEPP, Philip, ZWINGERS, Thomas, FRIEDL, Thomas W. P, LORENZ, Ralf, TESCH, Hans, FASCHING, Peter A

Volltext

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial von Stevic, Ines, Müller, Volkmar, Weber, Karsten, Fasching, Peter A, Karn, Thomas, Marmé, Frederic, Schem, Christian, Stickeler, Elmar, Denkert, Carsten, van Mackelenbergh, Marion, Salat, Christoph, Schneeweiss, Andreas, Pantel, Klaus, Loibl, Sibylle, Untch, Michael, Schwarzenbach, Heidi

Volltext

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial von von Minckwitz, Gunter, Prof, Schneeweiss, Andreas, Prof, Loibl, Sibylle, Prof, Salat, Christoph, MD, Denkert, Carsten, Prof, Rezai, Mahdi, Prof, Blohmer, Jens U, Prof, Jackisch, Christian, Prof, Paepke, Stefan, MD, Gerber, Bernd, Prof, Zahm, Dirk M, MD, Kümmel, Sherko, MD, Eidtmann, Holger, MD, Klare, Peter, MD, Huober, Jens, Prof, Costa, Serban, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Hilfrich, Jörn, Prof, Khandan, Fariba, MD, Fasching, Peter A, Prof, Sinn, Bruno V, MD, Engels, Knut, MD, Mehta, Keyur, MBA, Nekljudova, Valentina, PhD, Untch, Michael, Prof

Volltext

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy von Denkert, Carsten, von Minckwitz, Gunter, Darb-Esfahani, Silvia, Lederer, Bianca, Heppner, Barbara I, Weber, Karsten E, Budczies, Jan, Huober, Jens, Klauschen, Frederick, Furlanetto, Jenny, Schmitt, Wolfgang D, Blohmer, Jens-Uwe, Karn, Thomas, Pfitzner, Berit M, Kümmel, Sherko, Engels, Knut, Schneeweiss, Andreas, Hartmann, Arndt, Noske, Aurelia, Fasching, Peter A, Jackisch, Christian, van Mackelenbergh, Marion, Sinn, Peter, Schem, Christian, Hanusch, Claus, Untch, Michael, Loibl, Sibylle

Volltext

Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses von Ellmann, Stephan, Wenkel, Evelyn, Dietzel, Matthias, Bielowski, Christian, Vesal, Sulaiman, Maier, Andreas, Hammon, Matthias, Janka, Rolf, Fasching, Peter A, Beckmann, Matthias W, Schulz Wendtland, Rüdiger, Uder, Michael, Bäuerle, Tobias

Volltext

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials von Denkert, Carsten, Seither, Fenja, Schneeweiss, Andreas, Link, Theresa, Blohmer, Jens-Uwe, Just, Marianne, Wimberger, Pauline, Forberger, Almuth, Tesch, Hans, Jackisch, Christian, Schmatloch, Sabine, Reinisch, Mattea, Solomayer, Erich F, Schmitt, Wolfgang D, Hanusch, Claus, Fasching, Peter A, Lübbe, Kristina, Solbach, Christine, Huober, Jens, Rhiem, Kerstin, Marmé, Frederik, Reimer, Toralf, Schmidt, Marcus, Sinn, Bruno V, Janni, Wolfgang, Stickeler, Elmar, Michel, Laura, Stötzer, Oliver, Hahnen, Eric, Furlanetto, Jenny, Seiler, Sabine, Nekljudova, Valentina, Untch, Michael, Loibl, Sibylle

Volltext

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer von von Minckwitz, Gunter, Eidtmann, Holger, Rezai, Mahdi, Fasching, Peter A, Tesch, Hans, Eggemann, Holm, Schrader, Iris, Kittel, Kornelia, Hanusch, Claus, Kreienberg, Rolf, Solbach, Christine, Gerber, Bernd, Jackisch, Christian, Kunz, Georg, Blohmer, Jens-Uwe, Huober, Jens, Hauschild, Maik, Fehm, Tanja, Müller, Berit Maria, Denkert, Carsten, Loibl, Sibylle, Nekljudova, Valentina, Untch, Michael

Volltext

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial von Untch, Michael, Prof, Loibl, Sibylle, MD, Bischoff, Joachim, MD, Eidtmann, Holger, MD, Kaufmann, Manfred, Prof, Blohmer, Jens-Uwe, Prof, Hilfrich, Jörn, Prof, Strumberg, Dirk, Prof, Fasching, Peter A, Prof, Kreienberg, Rolf, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Gerber, Bernd, Prof, Rezai, Mahdi, MD, Jackisch, Christian, Prof, Huober, Jens, Prof, Kühn, Thorsten, Prof, Nekljudova, Valentina, PhD, von Minckwitz, Gunter, Prof

Volltext

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study von Untch, Michael, Rezai, Mahdi, Loibl, Sibylle, Fasching, Peter A, Huober, Jens, Tesch, Hans, Bauerfeind, Ingo, Hilfrich, Jörn, Eidtmann, Holger, Gerber, Bernd, Hanusch, Claus, Kühn, Thorsten, du Bois, Andreas, Blohmer, Jens-Uwe, Thomssen, Christoph, Dan Costa, Serban, Jackisch, Christian, Kaufmann, Manfred, Mehta, Keyur, von Minckwitz, Gunter

Volltext

Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial von Loibl, Sibylle, Treue, Denise, Budczies, Jan, Weber, Karsten, Stenzinger, Albrecht, Schmitt, Wolfgang D, Weichert, Wilko, Jank, Paul, Furlanetto, Jenny, Klauschen, Frederick, Karn, Thomas, Pfarr, Nicole, von Minckwitz, Gunter, Möbs, Markus, Jackisch, Christian, Sers, Christine, Schneeweiss, Andreas, Fasching, Peter A, Schem, Christian, Hummel, Michael, van Mackelenbergh, Marion, Nekljudova, Valentina, Untch, Michael, Denkert, Carsten

Volltext

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparqui... von Müller, Volkmar, Gade, Stephan, Steinbach, Bettina, Loibl, Sibylle, von Minckwitz, Gunter, Untch, Michael, Schwedler, Kathrin, Lübbe, Kristina, Schem, Christian, Fasching, Peter A., Mau, Christine, Pantel, Klaus, Schwarzenbach, Heidi

Volltext

NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto von Untch, Michael, Jackisch, Christian, Schneeweiss, Andreas, Schmatloch, Sabine, Aktas, Bahriye, Denkert, Carsten, Schem, Christian, Wiebringhaus, Hermann, Kümmel, Sherko, Warm, Mathias, Fasching, Peter A, Just, Marianne, Hanusch, Claus, Hackmann, John, Blohmer, Jens-Uwe, Rhiem, Kerstin, Schmitt, Wolfgang D, Furlanetto, Jenny, Gerber, Bernd, Huober, Jens, Nekljudova, Valentina, von Minckwitz, Gunter, Loibl, Sibylle

Volltext

MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial von Jank, Paul, Gehlhaar, Claire, Bianca, Lederer, Caterina, Fontanella, Andreas, Schneeweiss, Karn, Thomas, Marmé, Frederik, Sinn, Hans-Peter, van Mackelenbergh, Marion, Sinn, Bruno, Zahm, Dirk-Michael, Ingold-Heppner, Barbara, Schem, Christian, Stickeler, Elmar, Fasching, Peter A, Nekljudova, Valentina, Taube, Eliane Tabea, Heppner, Frank, Müller, Volkmar, Denkert, Carsten, Loibl, Sibylle

Volltext

Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials von Werutsky, Gustavo, Untch, Michael, Hanusch, Claus, Fasching, Peter A., Blohmer, Jens-Uwe, Seiler, Sabine, Denkert, Carsten, Tesch, Hans, Jackisch, Christian, Gerber, Bernd, Schneeweiss, Andreas, Link, Theresa, Krug, David, Huober, Jens, Rhiem, Kerstin, Kühn, Thorsten, Vladimirova, Valentina, Nekljudova, Valentina, Loibl, Sibylle

Volltext

Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis von Trapp, Elisabeth, Janni, Wolfgang, Schindlbeck, Christian, Jückstock, Julia, Andergassen, Ulrich, de Gregorio, Amelie, Alunni-Fabbroni, Marianna, Tzschaschel, Marie, Polasik, Arkadius, Koch, Julian G, Friedl, Thomas W P, Fasching, Peter A, Haeberle, Lothar, Fehm, Tanja, Schneeweiss, Andreas, Beckmann, Matthias W, Pantel, Klaus, Mueller, Volkmar, Rack, Brigitte, Scholz, Christoph

Volltext